Expanding Medicaid Improves Outcomes in Gynecologic Malignancies, But is it Enough?
- PMID: 36348204
- DOI: 10.1245/s10434-022-12766-9
Expanding Medicaid Improves Outcomes in Gynecologic Malignancies, But is it Enough?
References
-
- Centers for Disease Control and Prevention. Gynecologic Cancer Incidence, United States—2012–2016. 2019. https://www.cdc.gov/cancer/uscs/about/data-briefs/no11-gynecologic-cance... . Accessed on 1 October 2022.
-
- Huepenbecker SP, Fu S, Sun CC, Zhao H, Primm KM, Giordano SH, Meyer LA. Medicaid expansion and postoperative mortality in women with gynecologic cancer: a difference-in-difference analysis. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12663-1 . - DOI
-
- Nicholas Z, Hu N, Ying J, Soisson P, Dodson M, Gaffney DK. Impact of comorbid conditions on survival in endometrial cancer. Am J Clin Oncol. 2014;37:131–4. - DOI
-
- Melamed A, Bercow AS, Bunnell K, et al. Age-Associated Risk of 90-Day Postoperative Mortality After Cytoreductive Surgery for Advanced Ovarian Cancer. JAMA Surg. 2019;154:669–71. - DOI
-
- Kotsopoulos J, Gronwald J, Karlan B, et al. Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation. Gynecol Oncol. 2018;150:85–91. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
